❤️Conditions & CareInvestigational GLP-1 Antagonist Shows Promise for Post-Bariatric Hypoglycemia in Phase III Trial
Data from the phase III LUCIDITY trial indicate that the investigational agent avexitide significantly lowered the frequency of severe low blood sugar episodes in adults …